Showing 461-470 of 7575 results for "".
Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.SDPA: Dr. Matthew Zirwas Discusses Benefits of Attending the Annual Conference
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-matthew-zirwas-discusses-benefits-of-attending-the-annual-conference/29510/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Matthew Zirwas, MD. Dr. Zirwas shares why he looks forward to lecturing at the annual meeting.SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Understanding Disparities in AD
https://practicaldermatology.com/series/updates-atopic-dermatitis/understanding-disparities-ad/29081/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks with Practical Dermatology about understanding disparities in atopic dermatitis and the socHow to Approach a Contract Negotiation
https://practicaldermatology.com/series/pa-perspectives/how-approach-contract-negotiation/29072/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides tips on how to approach a contract negotiation, including the importance of using objective data while negotiating.Innovative Techniques for Forehead Wrinkles, Acne Laser Treatment, and More
https://practicaldermatology.com/conferences/maui-derm-2024/innovative-techniques-for-forehead-wrinkles-acne-laser-treatment-and-more/20250/Valerie D. Callender, MD, discusses the 3 cases she presented at Maui Derm 2024: filling in deeply etched forehead wrinkles with a resilient hyaluronic acid filler, treating acne with the 1726 nanometer laser, and treating melasma with a triple-combo procedure that includes maintenance therapy.Preventing AD in High-Risk Infants
https://practicaldermatology.com/topics/atopic-dermatitis/preventing-ad-in-high-risk-infants/20223/Early initiation of short-term emollient use, especially one that contains colloidal oatmeal, can improve skin barrier function and slash the chances of developing atopic dermatitis in high-risk infants. Paul Horowitz, MD, a pediatrician in Valencia, CA, shares highlights from his talk on the STOP-APractical Approaches to Diagnosing and Treating Hair Loss
https://practicaldermatology.com/topics/hair-nails/practical-approaches-to-diagnosing-and-treating-hair-loss/23969/Hair loss is a common presenting issue for many dermatology patients and a daunting diagnosis for the dermatologist. Assessing hair issues is like examining tree rings; you are assessing the future by looking at the past. This is particularly challenging since the hair available for examination at tChanging Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysis